Viewing Study NCT01697618


Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2026-01-08 @ 6:39 PM
Study NCT ID: NCT01697618
Status: COMPLETED
Last Update Posted: 2017-01-04
First Post: 2012-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module